Purchase Order 36C25020P0937
- Not listed
- This federal contract award to Cardinal Health 414, LLC was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration. The $270,000.00 firm fixed price delivery order is for the radiopharmaceutical product Xofigo Radium 223. The contract has a completion date of February 1, 2019. Cardinal Health 414 is a subsidiary of the global healthcare services company Cardinal Health, Inc. and has previously delivered radiopharmaceuticals, diagnostic imaging agents, and other...
- This federal contract award, valued at $261,303.00, was issued by the Veterans Integrated Service Network 4 (VISN 4) of the U.S. Department of Veterans Affairs (VA) to Cardinal Health 414, LLC for the supply of the radiopharmaceutical product Xofigo (radium-223 dichloride). The contract is a firm fixed-price purchase order with an ultimate completion date of April 11, 2026. Cardinal Health 414, LLC is a subsidiary of the larger Cardinal Health, Inc., a global healthcare services company that...
- This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 4 (VISN 4) of the U.S. Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the supply of the radiopharmaceutical Xofigo (radium-223 dichloride) for prostate cancer treatment. The contract has a ceiling value of $170,415.00 and a period of performance through June 28, 2026. Cardinal Health 414, LLC is a major supplier of...
- This firm fixed-price purchase order contract was awarded by the Veterans Integrated Service Network 4 (VISN 4), a division of the U.S. Department of Veterans Affairs (VA), to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract has a ceiling value of $64,325.92 and is for the delivery of the radiopharmaceutical Xofigo (radium-223 dichloride) to support nuclear medicine and oncology services for the VA healthcare system. The contract has an ultimate completion date of...
- This is a $31,018.03 firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Cardinal Health 414, LLC for the emergency supply of the radiopharmaceutical Xofigo (radium-223 dichloride) for prostate cancer treatment. Cardinal Health 414 is a subsidiary of the global healthcare services company Cardinal Health, Inc. and specializes in providing radiopharmaceuticals and related products to federal agencies, including the VA, Department of Defense, and National...
- This federal contract award is for the delivery of the radiopharmaceutical product XOFIGO (radium-223 dichloride) to the U.S. Department of Veterans Affairs (VA). The $283,002.51 firm fixed-price delivery order was awarded to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., a global healthcare services company specializing in the distribution of pharmaceuticals and medical products. The contract has an ultimate completion date of September 30, 2026. Cardinal Health 414, LLC is...
- This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 17 to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the supply of Xofigo (radium-223 dichloride), a radiopharmaceutical therapy for prostate cancer treatment. The contract has a ceiling value of $110,610.65 and a period of performance ending on February 28, 2025. Cardinal Health 414, LLC is a prominent supplier of...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 awarded a $15,863.85 firm-fixed-price purchase order to Cardinal Health 414, LLC for the delivery of an emergency dose of the radiopharmaceutical Xofigo. Cardinal Health 414, LLC is a subsidiary of the global healthcare company Cardinal Health, Inc. that specializes in providing radiopharmaceuticals and other medical products to federal agencies such as the VA, Department of Defense, and...
- This is a federal contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the delivery of radiopharmaceuticals, diagnostic imaging agents, nuclear medicine supplies, and specialty pharmaceuticals such as Xofigo cancer treatment. The contract has a potential value of $605,521.00 and was awarded on a firm fixed price basis without any set-aside designation. Cardinal Health...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a $218,360.00 firm fixed price purchase order contract to Cardinal Health 414, LLC Nphs Division, a subsidiary of Cardinal Health, Inc. The contract is for the delivery of Radium (Ra) 223 Dichloride (Xofigo), a radiopharmaceutical product used for the treatment of cancer. The contract does not have a set-aside designation and will run through May 31, 2024. Cardinal Health 414 is an experienced federal...
This federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The $109,948.16 firm fixed price contract is for the delivery of the radiopharmaceutical product Xofigo Radium Ra 223 Dichloride. The contract, which has a completion date of March 31, 2021, was not set aside for any specific business type. Cardinal Health 414 holds several indefinite delivery vehicles (IDVs) to provide radiopharmaceuticals and related products to VA medical facilities across the country, including a $39.8 million IDV for VA hospitals in Florida and the Caribbean, a $6.9 million IDV for the VA North Texas Health Care System, and a $3 million IDV for VA Midwest hospitals. These contract awards demonstrate Cardinal Health 414's ongoing role as a prime contractor supplying specialized pharmaceuticals and nuclear medicine support services to the VA and other federal healthcare agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Supplemental Agreement for work within scope | ($361) | 1/4/21 | |
| P00001 | Supplemental Agreement for work within scope | $8.4k | 10/26/20 | |
| Not listed | Not listed | $101.9k | 4/1/20 |